[This review was originally posted at the Nieman Journalism Lab Flagyl Price, on Feb. 18, 2011.]
Apple lays down its terms: Publishers have been quite anxiously awaiting word from Apple about the particulars of its subscription plan for mobile devices including the iPad; they got it this week, but it wasn't what a lot of them were hoping for. The New York Times summarized publishers' initial reaction with a few of the basic details — Apple gets a 30 percent cut, owns subscriber data (whether to send data to publishers is up to the subscriber), Get Flagyl, and publishers' options for subscription services outside Apple are limited.
The Lab's Josh Benton aptly laid out some of the primary implications for news organizations: Apple is setting itself up as toll-taker on the new news highway and putting a heavy incentive on converting print readers to tablet readers, but not putting restrictions on browser access within its devices. Media analyst Ken Doctor offered two astute takes on what Apple's proposal will entail; we'll call them glass-half-full and glass-half-empty.
Most of the reaction to Apple's deal, however, was overwhelmingly negative, Flagyl Price. Media consultant Alan Mutter pointed out a couple of gotchas for publishers, Dan Gillmor called Apple's policy stunningly arrogant and the publishers that sign up for it "insane, or desperate, Flagyl from mexico," ITworld's Ryan Faas called it "gouging content producers," Gizmodo's Matt Buchanan dubbed it "evil," developer Ryan Carson urged users to fight Apple's "extortion," and a Wall Street Journal raised possible antitrust issues.
The beef that most of these critics have with Apple is not so much the 30 percent cut (though that's part of it) as it is Apple's restrictions on publishers' alternative subscription methods. Effects of Flagyl, Apple is requiring that publishers that want to have a non-App Store subscription method can't charge less than their Apple-sanctioned route, and can't show app users how to access it, either. This means that, as Buchanan states, "Effectively, all easy roads to getting content on the iPad now run through Apple." (Plus, where can i buy Flagyl online, as TechCrunch's Erick Schonfeld noted, those terms could easily become even worse once Apple has publishers and readers hooked.)
Of course, the system looks a bit different from the consumer's perspective — it may be the most user-friendly subscription system ever, argued MG Siegler of TechCrunch. Flagyl Price, (Publishers, of course, disagreed about that.) As GigaOm's Mathew Ingram pointed out, this may come down to how much publishers think it's worth to have Apple handle their mobile sales for them.
We got some mixed early signs about how publishers might answer that question. Purchase Flagyl, PaidContent reported on publishers who felt Apple's terms could have been much worse, and Poynter's Damon Kiesow talked to publishers who plan to offer multiple options. Popular Science became the first magazine to jump on board and Wired is following ASAP, but Time Inc. pre-emptively struck deals with Apple's competitors, and another publishers' group threatened to take its business elsewhere.
One Pass to rule them all?: As if to underscore that point, Google announced its own One Pass digital paid-content system the next day, Flagyl dangers. Unlike Apple, Google will keep about 10 percent of publishers' revenue and allow publishers to own their subscribers' data, according to Advertising Age, Flagyl Price. Much of the commentary about Google's plan positioned it in opposition to Apple's proposal: The Wall Street Journal described it as a fired salvo at Apple, search guru John Battelle summed it up as "Hey Apple, we've got a better way," Alan Mutter detailed the ways Google's plan "trumps" Apple's, and others from The Next Web, Flagyl dose, mocoNews, and Fast Companycompared the two proposals.
But several others — particularly the Lab's Josh Benton and Poynter's Rick Edmonds — explained that while it might seem natural to compare Google's system to Apple's given the timing of their announcements, Google One Pass is focused far more on web access than app access, making the paid-content company Journalism Online a more direct competitor than Apple. Journalism Online's Gordon Crovitz made the case to paidContent for his company over Google, highlighting its flexibility, and paidContent also noted that newspaper chain MediaGeneral is trying out both systems at different papers, Flagyl description.
A couple of other notes on Google's plan: TechCrunch's MG Siegler argued that Google's agreement to allow publishers ownership of subscribers' data is at least as big of a deal to publishers as the revenue split, and GigaOM's Mathew Ingram ripped One Pass, saying that as long as its clients' content is on the open web without the exceptional user experience of the best apps, it's just "a warmed-over content paywall."
Parsing out the 'social media and revolutions' debate: Despite having been declared "over" early this week by The Daily's editor-in-chief, the protests in Egypt continued to dominate conversation, Purchase Flagyl online, including in future-of-news circles. Via The New York Times, we got a glimpse into how Egyptian officials were able to shut down their country's Internet and Facebook is wrestling with its role in the protests. NPR's Andy Carvin continued to earn plaudits (from The New York Times and PR exec Katie Delahaye Flagyl Price, ), and the Lab's Megan Garber looked at the way Carvin spontaneously launched a personalized Twitter pledge drive.
But the bulk of the discussion revolved around the same discussion that's been on slow burn for the past few weeks: What role does social media play in social activism. Washington grad student Deen Freelon has once again produced a fantastic synopsis of what we know and what we have yet to learn in this arena, so consider this a supplement to his post.
The parade of articles arguing that Twitter doesn't cause revolutions continued at a steady pace this week, Flagyl steet value, prompting NYU j-prof to profile the Twitter-debunking article as a genre, concluding that that argument — along with the glib social media triumphalism it's refuting — is a cheap detour around actually thoughtfully considering the complex issues involved in social change. Several others built on Rosen's point: Aaron Bady delved deeper into the social media-debunking article's function, CUNY j-profs Jeff Jarvis and C.W. Anderson focused on protecting those technological tools, and opined on the difference between academic and popular discourse on cause-and-effect, Flagyl brand name, respectively.
That doesn't there aren't substantive things to say about social media's role in recent protests, of course, Flagyl Price. POLIS' Charlie Beckett noted that newly adopted technologies (such as mobile phones) have helped create a more "networkable" power structure in the Middle East, and NDN's Sam duPont looked at social media's role as organizing tool, news source, and public sphere in Egypt.
To pay or not to pay: With a few exceptions (Frederic Filloux's short, fierce takedown of The Huffington Post as a "digital sand castle" is well worth a read), Flagyl forum, the second week of commentary on AOL's purchase of The Huffington Post centered on the question of whether HuffPo's thousands of unpaid contributors should start getting paychecks for their work.
At The New York Times' FiveThirtyEight blog, Nate Silver attempted to calculate the worth of a typical HuffPo post, concluding that they follow a classic power law relationship and that most of them aren't worth much. The New York Observer's Ben Popper said Silver is undervaluing HuffPo's contributors, Where can i cheapest Flagyl online, and Gannett's Ryan Sholin made the point that having those posts within a single platform is worth more than the posts themselves. Flagyl Price, Most of the grist for this week's conversation, though, came from Silver's Times colleague, David Carr, who used HuffPo as an entree into some observations about creating online content for others for free through platforms like Facebook, Twitter, and Quora. Paul Gillin of Newspaper Death Watch built on Carr and Silver's analyses to make the case that in the face of devalued online content, demand for higher-quality material might bring us out of the basement of online pay.
Several others countered Carr with similar points: Web thinker Stowe Boyd, British j-prof Paul Bradshaw and HuffPo's own Nico Pitney said HuffPo bloggers have eminently legitimate non-monetary reasons for writing there, GigaOM's Mathew Ingram pointed out that The Times' op-ed system isn't much different from HuffPo's, and Jeff Jarvis said news folks should be thinking more about value than content, order Flagyl online c.o.d.
Reading roundup: Some interesting bits and pieces to round out the week:
— Google unveiled the latest tool in its effort to fight content farms this week — an extension to its browser, Chrome, that allows users to block any site they choose from Google search results. TechCrunch called it "crowdsourcing" their content farm detection, and Gizmodo said that it allows for the arresting possibility of "an internet that never disagrees with you."
— A few miscellaneous items regarding The Daily: Slate's chairman, Herbal Flagyl, Jacob Weisberg, ripped it ("It’s just a bad version of a newspaper in electronic form with a very condescending view of the audience"), Scott Rosenberg wondered what'll happen to its archives, and the publication updated its glitch-ridden app.
— A couple of great data journalism resources: Poynter's Steve Myers broke down the difficulties in integrating data journalism into the newsroom, and ProPublica's Dan Nguyen wrote a wonderful post encouraging journalists to get started with data analysis, Flagyl Price.
— The second blogging Carnival of Journalism, focusing on increasing the number of news sources within communities, began going up over the past day or so, so keep an eye out for those posts. I'll have a roundup here next week.
— If you want a 30,000-foot summary of what's happening on the leading edge of news right now, you really can't do much better than Josh Benton's speech posted here at the Lab. It's a fantastic primer, no matter how initiated you already are.
Similar posts: Zoloft Price. Tramadol Mg. Cephalexin Cost. Buy Lipitor without prescription. Is Armour safe. Purchase Lipitor online.
Trackbacks from: Flagyl Price. Flagyl Price. Flagyl Price. Where can i find Flagyl online. Flagyl images. Flagyl treatment.
[This review was originally posted at the Nieman Journalism Lab Glucophage Price, on Feb. 11, 2011.]
AOL scoops up Arianna: The week's biggest media story was broken just a couple of hours after the Super Bowl on Sunday, when Kara Swisher of All Things D reported that AOL would buy The Huffington Post for $315 million (here's video of her interview with Arianna Huffington and AOL CEO Tim Armstrong). Swisher's post and this New York Times article provide just about all the background information you should need on the deal, along with The Huffington Post's press release and Huffington's column on the acquisition. Glucophage canada, mexico, india, The deal was seen by many as a bold one — a "fourth-quarter Hail Mary pass," as The New Yorker's Ken Auletta wrote — and reaction on the web (also summed up well by GigaOM's Mathew Ingram) was decidedly mixed. The thumbs-ups came from a eclectic mix of critics: Henry Blodget of Business Insider called it a smart risk, Reuters' Felix Salmon and All Things D's Peter Kafka said the two companies' needs fit each other well, with AOL getting a clear editorial voice (Salmon) and a "content-making machine" (Kafka). CUNY j-prof Jeff Jarvis said what AOL will find most valuable in HuffPo will not be content, but "a new cultural understanding of media that is built around the value of curation, the power of peers, the link economy, passion as an asset, and celebrity as a currency."
There were also plenty of people who shook (or at least scratched) their heads at the deal, including many of HuffPo's own readers and writers, Glucophage Price. Shira Ovide of The Wall Street Journal called it AOL's admission that its content strategy isn't working, and industry analyst Alan Mutter said AOL overpaid, online buy Glucophage without a prescription. The Guardian's Jemima Kiss blasted the move as "soullessly commercial," and Salon vet Scott Rosenberg contended that Huffington's once-distinctive brand will dissolve into AOL's bland corporatism. PaidContent's David Kaplan, Dan Lyons, and Om Malik of GigaOM both pointed to advertising struggles, Discount Glucophage, with Malik arguing that AOL has "not yet come to terms with the futility of chasing page views."
A few themes came up repeatedly in commentary about the two companies; one was HuffPo's expertise in that notorious (some would say dark) art known as search engine optimization. Salon's Alex Pareene declared the new organization "the single largest SEO-gaming operation ever created" and the LA Times' James Rainey explained the appeal that the Post's SEO skills bring. Slate's Farhad Manjoo (who wins this week's award for best lead) made the case that AOL/HuffPo's SEO-heavy strategy is risky in the long-term because "they won't be able to fool the computers forever." (Capital New York's Tom McGeveran made a similar point Glucophage Price, .) HuffPo's new AOL corporate empire-mate, Paul Carr of TechCrunch, reaffirmed his hatred for HuffPo's SEO tactics but said the deal could still be a good one for AOL.
The second theme was the fact that the Post doesn't pay most of its writers, a strategy that Tim Rutten of the Los Angeles Times likened to "a galley rowed by slaves and commanded by pirates." Dan Gillmor's tone was a bit milder, but he, Glucophage samples, too, urged Huffington to start paying her most productive bloggers, and Northeastern j-prof Dan Kennedy wondered whether bloggers might be less willing to go unpaid under a mega-corporation like AOL. Reason's Matt Welch defended Huffington against Rutten's charges, and Time's James Poniewozik said it's possible AOL/HuffPo could be signaling a move toward more expensive, Australia, uk, us, usa, quality content.
A few miscellaneous pieces of sharp commentary: GigaOM's Mathew Ingram said AOL needs HuffPo to help its other online content initatives figure out how the Internet works, and media analyst Ken Doctor saw AOL/HuffPo as a potential free alternative to Rupert Murdoch's steadily building paid-content empire. There were also plenty of posts about what the political viewpoint of the new organization would be, and while I haven't waded into that discussion, I do like NYU j-prof Jay Rosen's concept of "ideological innovation" in online journalism.
Changing coverage of a changing world: As the protests in Egypt have continued, so has the conversation about its media-related implications, and just as in last week, much of the talk centered on Al Jazeera, Glucophage Price. The New York Times examined the network's influence on the protests, Glucophage natural, as well as its efforts to gain more access to American viewers. Throughout the past two weeks, as the Lab's Justin Ellis and Twitter's Robin Sloan pointed out, Al Jazeera has been using social media to distribute its news to American audiences. Meanwhile, Glucophage overnight, Sheila Carapico at Foreign Policy argued that Al Jazeera and other TV networks can't give us a full picture of what's going on in Egypt.
There's been other fantastic journalism arising from the Egyptian protests, including the work of NPR's Andy Carvin to curate news and voices of the conflict on Twitter. Glucophage Price, In an illuminating interview with The Atlantic, Carvin argued that curation — the process of capturing the most elements of a story from various sources and passing them along — has always been a part of journalism. In a more academic piece at the Lab, USC grad student Nikki Usher explained how the protests are expanding the idea of a media event, with social media, webstreams, Glucophage cost, and the mainstream media "all working together to create a much larger, more nuanced picture of the live broadcasting of history."
The debate over social media's role in revolutions continued to roil, with several more writers responding to Malcolm Gladwell's brief New Yorker post arguing that the role Twitter & Co. in social activism like the Egyptian protests is overrated. UT-Dallas prof David Parry, Glucophage images, The Awl's Maria Bustillos, new media exec Rex Hammock, UMBC prof Zeynek Tufekci, and web philosopher David Weinbergerall weighed in with their rejoinders to Gladwell, in a discussion that Washington grad student Deen Freelon has mapped out far more expertly than I could.
Speeding up The Daily: The negative buzz around The Daily that began last week continued to pile up this week, leading to, Glucophage use, among other things, a "We're listening" blog post by the new "tablet newspaper." One of the issues that drew criticism was The Daily's long load time, as John Gruber of Daring Fireball compared it unfavorably to Flipboard, and paidContent's Staci Kramer explained her own loading glitches. Both Gruber and Kramer argued that while it seem minor, load time is a big deal to users, and The New York Times' Nick Bilton made a similar point: By being too slow and bulky, digital magazines like The Daily "almost defeat one of their main intended purposes, the promise of instant access to content and information."
The reviews kept pouring in as well, led by an insightful critique of The Daily's design by Stephen Coles at Fonts In Use, Glucophage Price. The primary criticism continued in the same vein as last week: The Daily's content just doesn't cut it. John Gapper of the Financial Times and Skip Ferderber of Crosscut made the point this week, Glucophage wiki, and Poynter's Damon Kiesow noted that new content is tough to find. Paul Davis of Shareable also chimed in with a criticism of The Daily's shortcomings with limited sharing options.
But there were a few who were generally impressed with The Daily's first week, including MinnPost's John Dreinan and industry analyst Alan Mutter, who liked its concise storytelling, multimedia integration and interactive advertising. Damon Kiesow and The Columbia Journalism Review's Lauren Kirchner both looked to other media efforts for lessons for The Daily — Kiesow to various other iPad apps, and Kirchner to the mid-1990s debut of Slate and Salon, Glucophage no prescription.
Gawker evolves the blog: We've been hearing about it since November, and this week Gawker officially launched its redesign, which reflects to a more magazine-style emphasis from a purer blog format. The Lab's Megan Garber captured what the move means Glucophage Price, particularly in terms of Gawker's advertising strategy, explaining how it's appropriated parts of the TV and magazine models to capitalize on its brand as a whole: "It’s moved, it seems, beyond simply selling its readers to advertisers. Now, it is simply selling itself."
Former Gawker Media contributor Latoya Peterson pointed to the outrage by Gawker blogs' readers and used it to argue that Gawker's new, My Glucophage experience, more controlled design is subverting the fast-posting, skim-friendly style it helped make a blogging standard. Rex Sorgatz was also skeptical of the change, asserting that the redesign would have to be rolled back or reworked within months and challenging anyone to bet him otherwise — a wager that was taken up by Gawker chief Nick Denton himself, using pageviews as the determining factor.
TBD takes a step back: TBD, a online local news operation based in Washington, real brand Glucophage online, D.C., debuted last August to much fanfare, but it took a major hit when the Washington Post reported that its owner Robert Allbritton (who also owns Politico) would have his local TV station WJLA take it over. TBD editor-in-chief Erik Wemple told the Lab's Megan Garber that the move wouldn't be as bad as it appeared, but it was still widely interpreted as "a retreat from the original vision of TBD, Purchase Glucophage online no prescription, " in the Post's words. Jim Brady, the site's former general manager, called it "not good news," and NYU j-prof Jay Rosen summed it up as "the TV guys won."
In the wake of the news, several observers expressed their frustration: Media consultant Mark Potts ripped Allbritton for not allowing the site breathing room to innovate, and media analyst Janet Coats held it up as an example of old media's resistance to change. Terry Heaton and Lost Remote's Cory Bergman used the episode to talk about the tensions involved when TV stations are affiliated with online media efforts, Glucophage Price.
Reading roundup: There's still quite a bit to get to, but I'll run through it quickly:
— Re Wikileaks: New York Times executive editor Bill Keller edged toward defining WikiLeaks as something a lot like journalism, The Nation's Greg Mitchell explained why the mainstream media is skeptical of WikiLeaks, the Personal Democracy Forum's Micah Sifry and NYU prof Clay Shirky gave some reasons for WikiLeaks' revolutionary nature, and at The Guardian, Evgeny Morozov argued that WikiLeaks can't continue much longer in its current form.
— Yahoo announced a move toward more personal content, particularly tablet-based. The New York Times explained why.
— At the National Sports Journalism Center, Jason Fry wrote a wonderful piece talking about how much less valuable scoops have become in a commoditized news world, and what journalists should do as a result. Craig Calcaterra of the baseball blog Hardball Talk expanded on the idea, offering a vision for the role of bloggers and reporters in a commodity-news environment.
— Two pieces to chew on this weekend, one short and one long: Dave Winer's plea to news organizations to join their communities online, and The New Yorker's Adam Gopnik's musings on the Internet and our interior lives.
Similar posts: Glucophage Mg. Retin A For Sale. Flagyl Over The Counter. Retin A mg. Discount Cipro. Buy Zoloft online cod.
Trackbacks from: Glucophage Price. Glucophage Price. Glucophage Price. Where can i find Glucophage online. Glucophage natural. Glucophage samples.
[This review was originally posted at the Nieman Journalism Lab Bactrim Cost, on Feb. 4, 2011.]
Al Jazeera, the network, and social activism: For the last week, the eyes of the world have been riveted to the ongoing protests in Egypt, and not surprisingly, the news media themselves have been a big part of that story, Bactrim interactions, too. Many of them have been attacked by President Hosni Mubarak's lackeys, but the crisis has also been a breeding ground for innovative journalism techniques. Mashable put together a roundup of the ways journalists have used Twitter, Facebook, streaming video, Bactrim without a prescription, Tumblr, and Audioboo, and the Lab highlighted reporting efforts on Facebook, curation by Sulia, and explainers by Mother Jones. Google and Twitter also created Speak to Tweet to allow Egyptians cut off from the Internet to communicate.
But the organization that has shined the brightest over the past 10 days is unquestionably Al Jazeera, Bactrim Cost. The Qatar-based TV network has dominated web viewing, and has used web audio updates and Creative Commons to get information out quickly to as many people as possible, Bactrim long term.
Al Jazeera also faced stiff censorship efforts from the Egyptian government, which stripped its Egyptian license and shut down its Cairo bureau, then later stole some of its camera equipment. Through it all, the broadcaster kept up live coverage that online and offline, was considered the most comprehensive of any news organization. Low dose Bactrim, As Lost Remote's Cory Bergman pointed, Al Jazeera's coverage showed the continued power of compelling live video in a multimedia world.
Salon's Alex Pareene called Al Jazeera's coverage Bactrim Cost, an indictment on the U.S.' cable networks, and CUNY j-prof Jeff Jarvis and others urged cable companies to carry Al Jazeera English. Tech pioneer Doc Searls used the moment as a call for a more open form of cable TV: "The message cable should be getting is not just 'carry Al Jazeera,' but 'normalize to the Internet.' Open the pipes. Give us à la carte choices. Let us get and pay for what we want, not just what gets force-fed in bundles."
The protests also served as fresh fuel for an ongoing debate about the role of social media in social change and global political activism. Several critics — including Wired's David Kravets, Bactrim no rx, The New Yorker's Malcolm Gladwell, and SUNY Oswego prof Ulises Mejias— downplayed the role of social media tools such as Twitter in protests like Egypt's. Others, though, countered with a relatively unified theme: It's not really about the media tools per se, but about the decentralized, hyperconnected network in which they are bound up. J-profs Jeremy Littau and Robert Hernandez, along with GigaOM's Mathew Ingram, wrote the most thoughtful versions of this theme, and they're all worth checking out, Bactrim Cost.
Tepid reviews for The Daily: Within the bubble of media geeks, one story dominated the others this week: On Wednesday, Rupert Murdoch's News Corp. released The Daily, the first daily updated news publication produced specifically for the iPad. Bactrim photos, If you can't get enough coverage of The Daily, go check out Mediagazer's smorgasbord of links. I'll try to offer you a digestible (but still a bit overwhelming, I'll admit) summary of what people are saying about it.
Leading up to Wednesday's launch, Poynter's Damon Kiesow found many of the people who are working for the heretofore secretive publication, and media analyst Alan Mutter and All Things Digital's Peter Kafka examined the reasons why it might or might not take off. Bactrim Cost, Once the app was released Wednesday afternoon, the reviews came pouring in.
First, buy Bactrim online cod, the good: The first impressions of most of the digital experts polled by Poynter were positive, with several praising its visual design and one calling it "what I’ve always hoped newspapers would do with their tablet editions." PaidContent's Staci Cramer was generally complimentary, and The Guardian's Ian Betteridge gave it a (not terribly enthusiastic) "buy."
Most of the initial reviews, though, were not so kind. Much of the 'meh' was directed at lackluster content, Where can i find Bactrim online, as reviewer after reviewer expressed similar sentiments: "a general-interest publication that is not generally interesting" (The Columbia Journalism Review); "Murdoch’s reinvention of journalism looks a lot like the one before it" (Macworld); "fairly humdrum day-old stories that you might read in, well…a regular old printed newspaper" (Mathew Ingram); "little [of Murdoch's money], it appears, has been invested in editorial talent" (Mashable); "the Etch A Sketch edition of Us Magazine" (Alan Mutter); "barely brings digital journalism into the late 20th century, much less the 21st" (Mark Potts).
The bulk of that criticism seemed to be built on two foundational questions, asked by the Lab's Joshua Benton, which The Daily has apparently yet to answer convincingly: "Who is The Daily trying to reach, order Bactrim from mexican pharmacy. What problem is it trying to solve?" TechCrunch (and several of the above reviewers) asked similar questions, and GigaOM's Darrell Etherington attempted an answer, arguing that it's not for the obsessively-Twitter-checking news junkies, but iPad users struggling to adjust to life after newspapers.
A few other issues surrounding The Daily that drew attention: One was its separation from the web by virtue of its place within the proprietary iTunes Store and iPad, as well as the complete lack of links in or out, Bactrim Cost. (That hasn't stopped an authorized daily index of links to the web versions of articles from springing up, though.) Salon alum Scott Rosenberg and j-prof Dan Kennedy led the charge against the walled garden, Bactrim dosage, while the Lab's Megan Garber pointed out the draconian anti-aggregation language on The Daily's AP content, and Justin Ellis wondered how user engagement will work in that closed environment.
Then there were the economics of the publication: Media analyst Ken Doctor had two good sets of questions about what it will take for The Daily to financially succeed (the latter is more number-crunchy). Jeff Jarvis also looked at some possible numbers, and media consultant Amy Gahran chastised Murdoch for investing so much money in the venture. Gahran also looked at the hazards of dealing with Apple, and paidContent's Staci Kramer noted that Murdoch wants Apple to lower its share of the subscription revenue. Bactrim Cost, And on the News Corp. front, Bactrim alternatives, Slate's Jack Shafer wrote about the role Murdoch's impatience will play in its fate, and Subhub's Evan Radowski gave us a history lesson on News Corp. initiatives like this one.
Apple strikes against e-publishers: In its ongoing tightening of App Store access and regulations, Apple made a significant move this week by rejecting a Sony iPhone app that would have allowed users to buy e-books from the Sony Reader Store. GigaOM's Mathew Ingram did a great job of putting the decision in the context of Apple's past moves, No prescription Bactrim online, explaining why they make good business sense: "What’s the point of controlling a platform like the iPhone and the iPad if you can’t force people to pay you a carrying charge for hosting their content and connecting them with their customers?"
But others (even at GigaOM) were more skeptical. Jason Kincaid of TechCrunch said the decision underscores the downside of closed content platforms, and posited that it's the first shot in a war between Apple and Amazon's Kindle, and Slate's Farhad Manjoo urged Amazon to pull its Kindle app out of the App Store. In another widely expected move along the same lines, Apple also told publishers that within two months, any app that doesn't take payments through its iTunes Store would be rejected, Bactrim Cost.
AOL follows Demand's content-farming path: We talked last week about Demand Media's explosive IPO and Google's intention to make content farms harder to find in searches, and we have a couple of updates to those issues this week. First, Seamus McCauley of Virtual Economics explained why he's skeptical about Demand's true valuation, not to mention its accounting methods, doses Bactrim work. And while Google's algorithm limiting content farms is not yet live, search engine startup Blekko has banned many content farm domains, including Demand's eHow, from its search results. Meanwhile, the debate over Demand continued, Buy no prescription Bactrim online, with Adotas' Gavin Dunaway and MinnPost's John Reinan delivering this week's broadsides against the company. Bactrim Cost, AOL hasn't been talked about as a content farm too much as of yet, but that may change after Business Insider's publication this week of a leaked internal document called "The AOL Way," which reads a lot like the textbook content farm strategy guide. GigaOM's Mathew Ingram and Fortune's Dan Mitchell blasted the plan, with Ingram asserting that "the chasing of eyeballs and pageviews is a game of constantly diminishing returns." Martin Bryant of The Next Web, on the other hand, said AOL's model is not a misguided, diabolical plan, but "an inevitable, turbo-powered evolution of what’s happened in the media industry for many years."
Reading roundup: A few things to check out this weekend while you're most likely snowed in somewhere:
— This week's WikiLeaks update: Julian Assange sat down with 60 Minutes for an interview (there's also a video on what it took to make that happen), buy cheap Bactrim, WikiLeaks was nominated for the Nobel Peace Prize, The Guardian's Alan Rusbridger gave his own account about working with WikiLeaks, and NYU's Adam Penenberg made the case for Assange as a journalist. Reuters also profiled the new WikiLeaks spinoff OpenLeaks.
— A few paid-content notes: The New York Times isn't releasing details of its paywall plan just yet, but it is fixing technological glitches with the system right now, while Media Week reported that some industry analysts are skeptical of its chances. Meanwhile, the Philadelphia Inquirer and Daily News announced they'll start offering an e-edition to paying subscribers.
— GigaOM founder Om Malik wrote a simple but insightful guide to creating a successful consumer Internet service, focusing on three elements: A clear purpose, ease of use, and fun.
— Harvard prof David Weinberger has a short, thought-provoking post offering a 21st-century update on Marshall McLuhan's famous "The medium is the message" aphorism: "We are the medium." It's a simple idea, but it has some potentially profound implications, a few of which Weinberger begins to flesh out.
Similar posts: Bactrim Dosage. Zoloft Cost. Bactrim Price. Cipro no prescription. Taking Retin A. Order Flagyl from mexican pharmacy.
Trackbacks from: Bactrim Cost. Bactrim Cost. Bactrim Cost. Purchase Bactrim online no prescription. Bactrim australia, uk, us, usa. Where can i find Bactrim online.